Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can a simple Eye-Movement exercise ease traumatic memories?

NCT ID NCT06469333

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether a self-administered technique called alternating bilateral stimulation (like moving your eyes side to side or tapping your shoulders) can make intrusive, distressing memories feel less intense and less vivid. Researchers will enroll 150 adults with symptoms of acute stress or PTSD who have not yet started therapy. Participants will use the technique on their own while focusing on a negative thought, and the study will measure changes in emotional distress and memory vividness.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 150 people

The number the study aims to enrol. It can still change while the study runs.

Started

Sep 2024

Expected to finish

Jun 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Present symptoms of acute stress (score between 22 and 35 on the Impact Event Scale-Revised, IES-R) and/or PTSD (higher score or equal to 36 on the IES-R), but at least present moderate to high psychological distress (score equal to or greater than 8 on the Kessler Abbreviated Psychological Distress Scale, K6); * Being in need of psychotherapeutic follow-up but not having started it yet; * Be aged between 18 and 65 years inclusive; * Speak and write French (be able to understand information and complete questionnaires independently); * Have good vision (being able to follow the movement of a white point on a screen); * Have good hearing and tactile abilities (being able to perceive auditory and tactile tones); * Have a computer equipped with a webcam; * Be informed and sign informed consent. Exclusion Criteria: * Be an adult protected under guardianship or curatorship; * Be a person subject to a judicial safeguard measure; * Present a lack of autonomy implying an impossibility in terms of administering questionnaires and filling out questionnaires; * Have a vision defect implying an impossibility of visual tracking of a white dot; * Present a hearing defect and/or tactile abilities implying an impossibility of perception; * Have a neurological condition constituting measurement biases (muscular dysfunctions, perceptual dysfunctions, etc.); * Suffer from psychotraumatic and dissociative disorders of complex type (respectively evaluated with regard to the anamestistic data of the patients and with a score greater than 25 on the dissociative experiences scale (Dissociative Experiences Scale, DES); * Do not present psychological distress (score less than 8 on the Kessler Abbreviated Psychological Distress Scale, K6) ; * Have a drug or alcohol dependence; * Benefit from ongoing psychotherapeutic monitoring; * Have already benefited from psychotherapeutic follow-up or have participated in studies in the last 6 months, both involving EMDR therapy.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Acute stress disorder are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Umr U1319 Inspiire

    RECRUITING

    Vandœuvre-lès-Nancy, 54505, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.